查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2096449

白內障手術器材：市場洞察、競爭格局及市場預測 - 2034 年

Cataract Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

白內障手術器械市場概況

概述：

  • 2025年全球白內障手術器械市值為91.5億美元，預計2034年將達到142.7億美元。
  • 在 2026 年至 2034 年的預測期內，市場預計將以 5.07% 的複合年成長率成長，這得益於白內障和視力障礙患病率的上升、加速白內障發作的文明病負擔的加重、老年人口的擴大以及主要製造商產品開發活動的活性化。
  • 按產品類型分類，預計到 2025 年，人工水晶體細分市場將佔 47% 的佔有率，從而推動白內障手術醫療設備市場的發展。
  • 按最終用戶分類，預計到 2025 年，醫院將佔 45% 的市場佔有率，引領白內障手術醫療設備市場。
  • 截至 2025 年，北美在白內障手術器械市場中佔最大佔有率，為 39%，但預計到 2034 年，亞太地區將實現最快成長。

白內障手術器械涵蓋眼科醫師用於治療白內障的所有儀器、設備和人工植入。白內障是一種眼球水晶體混濁的疾病，是全球可逆性失明的主要原因。這些器械的主要目的是透過移除混濁的天然晶狀體並植入透明的人工人工水晶體來恢復視力。市場結構是基於手術流程中使用的器械。超音波乳化系統利用超音波能量將白內障患者的人工水晶體擊碎並吸出，然後透過小切口取出，是現代白內障手術的主要技術。飛秒雷射實現了無需手術刀、電腦控制的關鍵手術步驟，例如角膜切開、囊膜切開和晶狀體碎裂，是飛秒雷射輔助白內障手術的基礎。人工水晶體是用於替代天然水晶體的植入，其設計包括單焦點、散光矯正型、多焦點和景深擴展型（EDF）等，是醫療設備中佔比最大的類別。眼科黏彈性手術器械是用於保護眼內組織和在手術過程中維持空間的黏彈性凝膠，產品線還包括各種器械、耗材和手術顯微鏡。全球白內障手術數量極高且持續成長，推動了市場需求。目前市場的特點是：高階屈光白內障手術的興起、飛秒雷射和機器人輔助平台的引入，以及人工智慧（AI）在手術規劃和引導中的應用。

白內障手術器械市場的主要市場促進因素

  • 白內障和視力障礙的盛行率正在上升。根據DelveInsight估計，全球約有24億人患有近視或遠視。
  • 治療方面的差距非常嚴重，只有 17% 的白內障視力障礙患者接受了有效的治療，這凸顯了巨大的未滿足需求。
  • 糖尿病、肥胖症和高血壓等文明病的日益普遍，正在加速白內障的早期發作。
  • 世界人口正在迅速老化，預計 60 歲及以上人口的比例將從 2015 年的 12% 上升到 2050 年的 22%，達到 21 億。
  • 患者對優質人工水晶體的認知和偏好不斷提高，這種晶體可以減少對眼鏡的依賴，並改善視力預後。
  • 技術正不斷進步，包括飛秒雷射手術、先進的人工水晶體、機器人輔助平台和人工智慧驅動的術前規劃。
  • 隨著主要製造商積極開發新產品和監管批准的增加，超音波和雷射手術平台正在被改造。

推動白內障手術器械市場成長的因素

市場促進因素

白內障和視力障礙的盛行率增加

白內障手術器械市場的主要驅動力是全球白內障和視力障礙盛行率的不斷上升，這直接促使了手術數量的成長，從而支撐了整個市場。白內障是眼球天然水晶體的混濁，仍然是全球失明和可逆性視力障礙的主要原因之一。根據DelveInsight估計，全球約有24億人患有近視或遠視。值得注意的是，治療方面的差距仍然顯著，僅有17%的白內障相關視力障礙患者接受了有效治療。這顯示存在巨大的未滿足需求，隨著人們對白內障的認知和治療可近性的提高，潛在需求還有很大的成長空間。白內障手術（即植入人工水晶體）是目前唯一能夠根治性的手術，也是世界上最常見的手術之一，因此盛行率的上升直接轉化為大量且可預測的手術需求。每次手術都需要消耗超音波盒、人工水晶體、黏彈性物質以及日益普及的飛秒雷射。隨著人們對白內障的認知不斷提高、醫療服務可及性不斷改善以及手術技術的進步，手術數量穩步成長，而有效且微創的視力恢復方案在醫療體系中也日益受到重視。隨著全球人口老化以及手術機構向醫療服務不足地區擴張，預計白內障手術市場將在預測期內持續成長。

文明病盛行率增加

全球與生活方式相關的代謝性疾病，尤其是糖尿病、肥胖和高血壓的盛行率不斷上升，是推動白內障手術器械市場發展的重要因素。這些疾病會加速白內障的發生和發展，使治療目標人口向更年輕的族群擴展。糖尿病尤其與白內障的早期發生密切相關，糖尿病患者出現水晶體混濁的時間往往比通常與老齡化相關的白內障發病年齡早數年甚至數十年。另一方面，肥胖症和高血壓會導致代謝和氧化壓力，加速水晶體退化。在飲食結構改變、久坐生活方式和都市化進程加快的背景下，這些疾病的全球盛行率持續上升，導致白內障患者群體不斷擴大，且發病年齡趨於年輕化，從而增加了對白內障手術和相關醫療設備的需求。這些年輕患者，通常正值工作年齡，對視力恢復抱有很高的期望，並且對能夠恢復完整視野的高階人工水晶體有著濃厚的興趣，這進一步加速了市場需求向高價值醫療設備的轉變。代謝性疾病的盛行率是一個持續且日益嚴重的全球趨勢，在新興市場尤其明顯，這些市場正逐步擴大手術機會。除了傳統的老齡化相關性白內障患者群體外，這構成了龐大且持續成長的需求來源，並將支撐市場在預測期內的持續成長。

市場限制因素

儘管白內障手術器械市場擁有廣泛且人口結構永續的需求基礎，但其成長速度和組成仍面臨許多限制因素。其中最顯著的是白內障手術併發症的風險。白內障手術雖然是醫學上最安全有效的手術之一，但仍有囊性黃斑部水腫、眼內炎和其他感染疾病、意外屈光不正以及人工水晶體脫位或移位（包括後囊膜混濁）等風險，後者可能需要屈光雷射治療。這些併發症會增加治療成本和複雜性，並可能影響視力預後，從而影響高價醫療設備的上市，使得外科醫生和患者對採用最新技術持謹慎態度。第二個併發症與監理和保險報銷有關。美國食品藥物管理局(FDA) 和歐盟醫療設備法規等機構嚴格且冗長的監管流程增加了新醫療設備上市所需的成本和時間，為小規模創新企業設定了很高的進入門檻。另一方面，保險報銷機制對目標市場有著決定性的影響。在大多數醫療保健系統中，公共和私人保險都涵蓋使用標準單焦點晶體的白內障手術，但與高階老花矯正晶體、散光鏡片或飛秒雷射輔助手術相關的額外費用卻不在保險範圍內，迫使患者自費承擔這些費用。這種保險覆蓋範圍的缺口將高階市場限制在那些有能力且願意支付的人群中，使其極易受到經濟週期的影響。其他限制因素包括先進手術平台、雷射設備和高階晶體的高成本，這限制了成本敏感型市場和發展中市場的普及。來自競爭激烈的市場和擁有大規模採購的公共機構的價格壓力，以及由於進口零件和成品關稅導致的成本和供應波動，也發揮作用。這些臨床、監管和經濟因素共同構成了支撐成長的結構性因素，但也導致了不同細分市場和地區發展過程的差異。資料來源：同行評審的眼科文獻、監管機構和公司資訊披露。

區域說明

北美洲

北美在市場規模和高級產品普及率方面佔主導地位，預計到2025年將佔39%的市場。該地區擁有大規模的白內障患者群體、先進的基礎設施、優惠的保險報銷機制以及高昂的醫療費用支出。根據美國國立衛生研究院（NIH）統計，超過50%的80歲以上人口患有白內障或接受過白內障手術；美國疾病管制與預防中心（CDC）估計，2022年美國有2050萬40歲以上的人口受到白內障的影響。同時，人口與社會研究所（PRB）預測，到2050年，65歲以上的患者人數將達到8,200萬人。美國是新平台和人工水晶體核准的標竿市場。短期趨勢受優質化、飛秒雷射和機器人技術的應用、人工智慧驅動的手術規劃以及門診手術的普及等因素的影響。

歐洲

歐洲是一個龐大的創新驅動型市場，其發展得益於人口老化、先進的醫療基礎設施以及患者對眼科保健的高度重視，越來越多的老年患者尋求白內障手術。根據英國政府統計，2023年英格蘭有超過516,073人因白內障手術住院，這充分說明了市場需求的規模。政府的大力支持、優惠的保險報銷方案以及領先製造商的持續創新，都有助於改善治療效果和提高醫療服務的可及性。例如，採用先進材料平台的景深擴展型人工晶體已獲得CE認證並在歐洲推廣應用。歐盟醫療設備法規（MDR）提高了新醫療設備核准所需的證據標準。

亞太地區

亞太地區是成長最快的地區，其特徵是手術量大，且由於人口眾多且老化，存在大量未被滿足的需求。市場呈現分層結構，飛秒雷射手術和高階晶體在都市區迅速普及，而傳統、經濟實惠的方法在農村地區仍然佔主導地位，高階國際公司與低成本的本土企業並存。在政府補助和宣傳宣傳活動的支持下，為解決白內障手術積壓問題，該地區正迅速向最新的超音波乳化技術和人工智慧在手術規劃中的應用邁進。中國佔了最大的成長佔有率，而印度則擁有龐大的患者群體、經濟高效的模式和本土生產能力。印度和新加坡的醫療旅遊進一步推動了需求。所有細分市場的成長率均超過全球平均。

世界其他地區

「世界其他地區」包括中東、非洲和南美洲。這些地區在醫療保健服務取得方面存在顯著差異。在波灣合作理事會（GCC）成員國和南美大型市場（尤其是巴西），對眼科手術系統的投資正在增加，高階屈光白內障手術的數量也在上升，使這些市場成為成長市場。另一方面，在非洲大部分地區，白內障導致的失明負擔非常沉重，但眼科醫師和手術基礎設施的嚴重短缺使得許多白內障治療需求無法滿足。費用和保險報銷的限制阻礙了高階手術的推廣。預計白內障推廣計畫、對手術系統的投資、公眾意識的提高以及來自區域和亞洲製造商的低成本醫療設備將推動該地區的成長。

白內障手術器械市場近期發展趨勢

2025年4月，愛爾康宣布推出UNITY玻璃體視網膜白內障系統與UNITY白內障系統。這些功能強大的平台，包括整合式主機和獨立式白內障系統，融合了多項市場首創技術，例如UNITY 4D FACO、HYPERVIT 30K和UNITY智慧流體系統，旨在提高白內障和玻璃體視網膜手術的效率和術後效果。戰略意義：作為市場領導者，愛爾康推出這一新一代整合平台，進一步強化了其將先進的FACO技術與智慧流體相結合的戰略重點，以期在降低能耗的同時，實現更高的精度、穩定性和效率。

2025年3月，愛爾康宣布，其廣泛應用的景深擴展型人工水晶體Vivity將更名為Clareon Vivity，採用該公司先進的Clareon鏡片材料。 Clareon Vivity已獲得CE認證，並將於2025年第二季開始在歐洲上市。戰略意義：愛爾康將其領先業界的景深擴展型光學技術升級為先進的疏水性丙烯酸酯材料，將卓越的光學性能與旨在減少後囊膜混濁和閃光的材料相結合，展現了其在高階人工晶狀體領域光學和材料方面的創新。

常見問題：

Q1. 白內障手術器械市場預期成長率是多少？

全球白內障手術器械市場預計在 2026 年至 2034 年的預測期內將以 5.07% 的複合年成長率成長。

Q2. 白內障手術器械市場的目前規模和預期規模是多少？

2025年全球白內障手術器械市值為91.5億美元，預計2034年將達到142.7億美元。

Q3.哪些地區正在推動白內障手術器械市場的發展？

預計到2025年，北美將以39%的市場佔有率引領白內障手術器械市場，這主要得益於人口老齡化導致的高白內障患病率、先進的醫療基礎設施、飛秒雷射和高階人工水晶體的廣泛應用、有利的保險報銷政策以及主要製造商的存在。根據美國國立衛生研究院（NIH）統計，80歲以上人口中超過50%患有白內障或已接受白內障手術。預計到2034年，亞太地區將實現最高的複合年成長率，這主要得益於中國、印度以及全部區域龐大的人口基數和人口老齡化、巨大的未滿足需求以及不斷擴大的手術能力。

目錄

第1章：引言

  • 調查範圍
  • 市場區隔
  • 市場概覽

第2章：白內障手術醫療設備：摘要整理

  • 主要亮點和市場概覽

第3章：白內障手術器械市場：關鍵因素

  • 市場促進因素
    • 白內障和視力障礙的盛行率增加
    • 文明病盛行率增加
    • 老年人口增加
    • 設備和外科手術技術的進步
  • 市場限制因素
    • 白內障手術併發症的風險
    • 監理和保險報銷方面的挑戰
    • 高成本和價格壓力
  • 市場機遇
    • 機器人輔助雷射手術的興起
    • 人工智慧與數位平台的融合

第4章 影響分析：人工智慧、地緣政治、貿易和經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：波特五力分析

  • 供應商的議價能力
  • 消費者議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的競爭

第7章：白內障手術器械市場評估

  • 依產品類型
    • 乳化系統
    • 飛秒雷射
    • 人工水晶體
    • 黏彈性手術器械
    • 其他
  • 最終用戶
    • 醫院
    • 專科診所
    • 門診手術中心
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：白內障手術器材市場的競爭格局

  • 競爭分析
  • 企業市場占有率分析（加值服務）

第9章：白內障手術器械市場的新創企業資金籌措和投資趨勢

第10章：公司簡介與產品簡介

  • Alcon Inc.
    • 公司簡介
    • 公司簡介
    • 財務概覽
    • 產品列表
    • 策略舉措/熵
  • Johnson & Johnson Services, Inc.
  • Bausch Health Companies Inc.
  • Carl Zeiss Meditec AG (ZEISS Group)
  • NIDEK CO., LTD.
  • HOYA Corporation
  • STAAR Surgical Company
  • Ziemer Ophthalmic Systems AG
  • Topcon Corporation
  • Oertli Instrumente AG

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0129

Cataract Surgery Devices Market Summary

Overview:

  • The global cataract surgery devices market was valued at USD 9.15 billion in 2025 and is projected to reach USD 14.27 billion by 2034.
  • The market is expected to expand at a CAGR of 5.07% during the forecast period 2026-2034, supported by the growing prevalence of cataracts and vision impairment, the rising burden of lifestyle disorders that accelerate cataract development, an expanding geriatric population, and rising product development activity among key manufacturers.
  • By product type, the intraocular lenses segment dominated the cataract surgery devices market with a 47% share in 2025.
  • By end-user, the hospitals segment dominated the cataract surgery devices market with a 45% share in 2025.
  • North America accounted for the largest share of the cataract surgery devices market at 39% in 2025, while Asia-Pacific is anticipated to register the fastest growth through 2034.

Cataract surgery devices encompass the full range of instruments, equipment, and artificial implants used by ophthalmologists to treat cataracts, the clouding of the eye's natural lens that is a leading cause of reversible blindness worldwide. The primary objective of these devices is to remove the clouded natural lens and replace it with a clear artificial intraocular lens to restore vision, and the market is organized upon the devices used across the surgical workflow. Phacoemulsification systems use ultrasonic energy to break up and aspirate the cataractous lens through a small incision and are the mainstay of modern cataract surgery. Femtosecond lasers enable a bladeless, computer-guided approach to key surgical steps including the corneal incision, capsulotomy, and lens fragmentation, underpinning femtosecond laser-assisted cataract surgery. Intraocular lenses are the artificial implants that replace the natural lens, spanning monofocal, toric, multifocal, and extended depth-of-focus designs, and they represent the largest device category. Ophthalmic viscosurgical devices are the viscoelastic gels that protect intraocular tissue and maintain space during surgery, and a range of additional instruments, consumables, and surgical microscopes complete the portfolio. Demand is anchored by the very high and rising global volume of cataract surgery, and the contemporary market is defined by the shift toward premium refractive cataract surgery, the adoption of femtosecond laser and robotic-assisted platforms, and the integration of artificial intelligence into surgical planning and guidance.

Cataract Surgery Devices Market Key Growth Drivers

  • Growing prevalence of cataracts and vision impairment, with DelveInsight estimating that some 2.4 billion people globally are affected by near or distance vision impairment.
  • A large treatment gap, with only 17% of those with cataract-related impairment having access to effective intervention, underscoring substantial unmet need.
  • Rising prevalence of lifestyle disorders such as diabetes, obesity, and hypertension that accelerate the early onset of cataracts.
  • A rapidly aging global population, with the share aged 60 and above projected to rise from 12% in 2015 to 22% by 2050, reaching 2.1 billion people.
  • Rising patient awareness and preference for premium intraocular lenses that reduce spectacle dependence and improve visual outcomes.
  • Continuous technological advancement, including femtosecond laser-assisted surgery, advanced intraocular lenses, robotic-assisted platforms, and AI-driven surgical planning.
  • Rising product development activity and regulatory approvals among the leading manufacturers, refreshing phacoemulsification and laser platforms.

Key Companies in Cataract Surgery Devices Market

The competitive field is led by a small group of large ophthalmic companies operating full cataract surgery portfolios that span phacoemulsification systems, femtosecond lasers, intraocular lenses, and viscosurgical devices, challenged by specialists in surgical platforms, lenses, and viscoelastics and by regional manufacturers competing on cost and access. The leading participants in the cataract surgery devices market include the following:

  • Alcon Inc.
  • Johnson & Johnson Services, Inc.
  • Bausch Health Companies Inc.
  • Carl Zeiss Meditec AG (ZEISS Group)
  • NIDEK CO., LTD.
  • HOYA Corporation
  • STAAR Surgical Company
  • Ziemer Ophthalmic Systems AG
  • Topcon Corporation
  • Oertli Instrumente AG

Factors Contributing to the Growth of the Cataract Surgery Devices Market

Market Drivers

Growing Prevalence of Cataracts and Vision Impairment

The foundational driver of the cataract surgery devices market is the growing global prevalence of cataracts and vision impairment, which generates the surgical volume on which the entire category depends. Cataract, the clouding of the eye's natural lens, remains one of the leading causes of blindness and reversible visual impairment worldwide, and DelveInsight estimates that some 2.4 billion people globally are affected by near or distance vision impairment. Critically, a large treatment gap persists, with only 17% of those with cataract-related impairment having access to effective intervention, which underscores an enormous unmet need and a substantial reservoir of latent demand that expands as awareness and access improve. Because cataract surgery with intraocular lens implantation is the only definitive treatment and is among the most commonly performed surgical procedures in the world, the rising prevalence translates directly into a large and predictable volume of procedures, each of which consumes a phacoemulsification pack, an intraocular lens, viscoelastic, and, increasingly, femtosecond laser time. Increasing awareness, improved access to healthcare, and advances in surgical technology have led to a steady rise in surgical procedures, and healthcare systems increasingly prioritize effective and minimally invasive solutions to restore vision. As the global population ages and as surgical capacity expands into underserved regions, the cataract-driven base of the market is expected to grow steadily throughout the forecast period.

Increasing Prevalence of Lifestyle Disorders

The rising global prevalence of lifestyle-related metabolic disorders, particularly diabetes, obesity, and hypertension, is a significant driver of the cataract surgery devices market because these conditions accelerate the onset and progression of cataracts and enlarge the treated population at younger ages. Diabetes in particular is strongly associated with the earlier development of cataracts, and diabetic patients frequently develop lens opacities years or decades before the typical age-related onset, while obesity and hypertension contribute to the metabolic and oxidative stress that hastens lens degeneration. As the global prevalence of these conditions continues to climb, driven by dietary change, sedentary lifestyles, and urbanization, the pool of patients developing cataracts expands and shifts toward younger age groups, escalating the demand for cataract surgery and the devices it requires. This younger, often working-age population brings heightened expectations for visual outcomes and a greater interest in premium intraocular lenses that restore a full range of vision, reinforcing the shift in mix toward higher-value devices. Because the metabolic-disease epidemic is a durable and worsening global trend that is particularly pronounced in the same emerging markets where surgical access is expanding, it adds a large and growing source of demand to the traditional age-related cataract base and supports the sustained expansion of the market over the forecast period.

Market Restraints

Despite a broad and demographically durable demand base, the cataract surgery devices market faces material constraints that temper the pace and mix of growth. The most prominent is the risk of surgical complications associated with cataract surgery. While cataract surgery is among the safest and most effective procedures in medicine, it carries risks including posterior capsule opacification, which is the most common late complication and can require a secondary laser procedure, as well as cystoid macular edema, retinal detachment, endophthalmitis and other infections, refractive surprise, and lens dislocation or decentration. These complications increase the cost and complexity of care, can compromise the visual outcome that justifies premium devices, and create caution among surgeons and patients in adopting the newest technologies. The second constraint is regulatory and reimbursement-related. Stringent and lengthy regulatory pathways from authorities such as the United States Food and Drug Administration and the European Union Medical Device Regulation raise the cost and time of introducing new devices and create a high barrier for smaller innovators, while reimbursement structures shape the addressable market in decisive ways. In most health systems, public and private insurance covers cataract surgery with a standard monofocal lens but not the substantial additional cost of premium presbyopia-correcting and toric lenses or of femtosecond laser assistance, which the patient must pay out of pocket, and this coverage gap restricts the premium market to those able and willing to pay and exposes it to economic cycles. Additional constraints include the high cost of advanced surgical platforms, lasers, and premium lenses, which limits penetration in cost-sensitive and developing markets; pricing pressure from competitive markets and high-volume public procurement; and the volatility that tariffs on imported components and finished devices add to cost and supply. Together, these clinical, regulatory, and economic factors ensure that growth, while structurally supported, proceeds unevenly across segments and geographies. Source: peer-reviewed ophthalmology literature; regulatory authorities; company disclosures.

Cataract Surgery Devices Market Segment Analysis

The global cataract surgery devices market is segmented by product type (phacoemulsification systems, femtosecond lasers, intraocular lenses, viscosurgical devices, and others); by end-user (hospitals, specialty clinics, and ambulatory surgical centers); and by geography (North America, Europe, Asia-Pacific, and the Rest of the World).

By Product Type

Dominant Subsegment: Intraocular Lenses.

The intraocular lenses category is expected to dominate the market.

Dominant: Intraocular Lenses ~ 47%

The intraocular lenses segment accounted for a 47% share of the cataract surgery devices market in 2025. Intraocular lenses dominate the product-type structure because they are the artificial implant that replaces the natural lens in every cataract procedure, making them indispensable and the single highest-value consumable in most cases. Their critical role in restoring vision after cataract removal, combined with the very high global volume of cataract surgery, concentrates market value in this category, and advances in lens technology have reinforced its leadership by raising the average selling price. Multifocal, trifocal, toric, and extended depth-of-focus designs have significantly enhanced patient outcomes by improving near, intermediate, and distance vision and by reducing spectacle dependence, and rising patient awareness of premium lens options, coupled with the demand for advanced refractive cataract surgery, is driving adoption toward these higher-value lenses. Strong product pipelines from the leading manufacturers and continuous innovation in lens materials and designs, exemplified by the approval of a full range of vision lenses and the migration of extended depth-of-focus optics onto advanced hydrophobic acrylic materials, reinforce the leadership of the segment. Phacoemulsification systems form the second product category and the capital anchor of the operating room; femtosecond lasers constitute the fastest-growing platform category through femtosecond laser-assisted cataract surgery; and ophthalmic viscosurgical devices are an essential high-volume consumable. Intraocular lenses are expected to remain the primary revenue contributor and to retain their leading share throughout the forecast period, supported by premiumization.

By End-User

Dominant Subsegment: Hospitals.

The hospitals category is expected to dominate the market.

Dominant: Hospitals ~ 45%

The hospitals segment accounted for a 45% share of the cataract surgery devices market in 2025. Hospitals dominate the end-user structure because they serve as the primary centers for surgical intervention, post-operative care, and patient management, and because they possess the advanced infrastructure, skilled ophthalmic surgeons, and access to cutting-edge technologies such as phacoemulsification systems, femtosecond lasers, and premium intraocular lenses that cataract surgery requires. This infrastructure enables the rapid adoption of innovative surgical solutions, and hospitals also contribute to raising awareness through outreach programs, eye camps, and public health initiatives that expand patient access to timely diagnosis and treatment. The increasing preference for hospital-based cataract procedures, driven by their ability to offer comprehensive care, higher safety standards, and favorable reimbursement, together with growing investment in modern surgical equipment and the rising demand for minimally invasive and precision-based procedures, further strengthens their role in device utilization. Ambulatory surgical centers form the fastest-growing end-user segment, as the minimally invasive and high-throughput nature of cataract surgery suits them ideally to the outpatient setting and as favorable reimbursement and improving technology support the migration of procedures into dedicated ambulatory facilities that offer efficiency, convenience, and lower cost. Specialty clinics play a substantial role in diagnosis, patient selection, premium refractive cataract surgery, and long-term management. Hospitals are expected to retain their leading share throughout the forecast period, even as ambulatory surgical centers grow faster.

Cataract Surgery Devices Market Region Analysis

Dominant Region: North America

Dominant: North America ~ 39% (Largest)

North America accounted for a 39% share of the global cataract surgery devices market in 2025. The region leads the global market, driven by the rising prevalence of cataracts and other vision-impairing disorders, coupled with risk factors such as an aging population, diabetes, and hypertension. According to the National Institutes of Health, over 50% of individuals aged 80 and above in the United States had cataracts or had undergone cataract surgery, and data from the Centers for Disease Control and Prevention indicate that an estimated 20.5 million Americans aged 40 and older were affected by cataracts in 2022, a substantial patient pool that continues to fuel demand for advanced surgical technologies including phacoemulsification systems, intraocular lenses, femtosecond lasers, and ophthalmic viscosurgical devices. Demographic trends further amplify market growth, as the Population Reference Bureau estimates that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, making age-related eye conditions increasingly prevalent, and hospitals and specialty eye clinics are adopting advanced cataract surgery platforms supported by favorable reimbursement and high healthcare spending. Ongoing research and development and product innovation strengthen the market further, exemplified by the United States clearance of a next-generation anterior cataract surgery system with advanced fluidics and vacuum control, and the strong presence of leading global manufacturers and continuous patient-awareness programs reinforce regional leadership. The region is expected to retain its dominant position throughout the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is projected to register the fastest compound annual growth rate in the cataract surgery devices market through 2034. The region is defined by a high volume of procedures and significant unmet medical need, driven by its large and aging population, and it is emerging as the principal growth engine of the market. The market exhibits a tiered structure, with a stark divide between urban centers that are rapidly adopting advanced technologies such as femtosecond laser-assisted cataract surgery and premium intraocular lenses, and rural areas that rely on more traditional and affordable methods; a key trend is the coexistence of high-end international manufacturers and low-cost domestic players that together broaden access across the price spectrum. The region is seeing a rapid shift toward modern phacoemulsification techniques and is at the forefront of adopting digital health solutions and artificial intelligence for surgical planning. Governments and public health organizations play a crucial role by providing subsidies and launching awareness campaigns to address the huge backlog of untreated cataracts, and the growth of medical tourism in countries such as India and Singapore, which offer high-quality yet affordable care, further boosts demand for advanced surgical devices. China contributes the largest incremental volume, supported by a vast aging population and a growing domestic industry; India combines a very large cataract burden with a high-volume, cost-efficient surgical model and significant domestic manufacturing; and Japan and South Korea contribute high-value, premium-weighted markets. Regional growth is expected to exceed the global average across every segment.

Regional Commentary

North America

North America leads on value and premium adoption, holding a 39% share in 2025. The region combines a large cataract patient pool with advanced infrastructure, favorable reimbursement, and high healthcare spending. The National Institutes of Health reports that over 50% of those aged 80 and above have had cataracts or cataract surgery, and the Centers for Disease Control and Prevention estimate 20.5 million Americans aged 40 and older were affected in 2022, while the Population Reference Bureau projects those aged 65 and older rising to 82 million by 2050. The United States is the reference market for new platform and lens approvals. Near-term dynamics are shaped by premiumization, femtosecond laser and robotic adoption, AI-driven surgical planning, and the outpatient migration of surgery.

Europe

Europe is a large and innovation-oriented market, supported by an aging population, advanced healthcare infrastructure, and high patient awareness of eye care, with a large pool of geriatric patients increasingly seeking cataract surgery. According to the Government of the United Kingdom, over 516,073 people were admitted to hospitals for cataract surgery in England in 2023, illustrating the scale of demand. Strong government support, favorable reimbursement, and continuous innovation by key manufacturers enhance outcomes and access, exemplified by the CE Mark approval and European rollout of an extended depth-of-focus lens on an advanced material platform. The European Union Medical Device Regulation has raised the evidentiary burden for new device approvals.

Asia-Pacific

Asia-Pacific is the fastest-growing region, defined by a high volume of procedures and significant unmet need driven by a large and aging population. The market is tiered, with urban centers rapidly adopting femtosecond laser surgery and premium lenses while rural areas rely on traditional and affordable methods, and high-end international and low-cost domestic players coexist. The region is shifting rapidly toward modern phacoemulsification and adopting AI for surgical planning, supported by government subsidies and awareness campaigns addressing the cataract backlog. China contributes the largest incremental volume, India combines a large burden with a cost-efficient model and domestic manufacturing, and medical tourism in India and Singapore further boosts demand. Growth exceeds the global average across every segment.

Rest of World

The Rest of the World comprises the Middle East, Africa, and South America. Access is highly stratified. The Gulf Cooperation Council states and the larger South American markets, particularly Brazil, have invested in ophthalmic surgical capacity and increasingly perform premium refractive cataract surgery, representing growing markets, while much of Africa carries a very high burden of cataract blindness alongside a severe shortage of ophthalmologists and surgical infrastructure, so a large share of cataract need is unmet. Cost and limited reimbursement constrain premium adoption. Regional growth will be driven by cataract-outreach programs, investment in surgical capacity, rising awareness, and lower-cost devices from regional and Asian manufacturers.

Cataract Surgery Devices Market Competitive Landscape

The global cataract surgery devices market is classified as Moderately Concentrated. A few key global players, including Alcon, Johnson & Johnson Vision, Bausch + Lomb, and Carl Zeiss Meditec, dominate the market through comprehensive portfolios spanning surgical platforms, lasers, and intraocular lenses, strong brand recognition among surgeons, global distribution, and continuous research and development. These companies maintain leadership through product innovation, strategic partnerships, mergers and acquisitions, and geographic expansion, while emerging players offering specialized or cost-effective solutions increase competition and drive technological advancement. The competitive landscape is evaluated across the following dimensions:

  • Market concentration: Moderately concentrated, with a small group of large ophthalmic companies holding the majority of global revenue through full-line surgical and lens portfolios, alongside a substantial tier of platform, lens, and viscoelastic specialists and regional high-volume manufacturers.
  • Leading players: Alcon and Johnson & Johnson Vision lead the market with comprehensive surgical and lens portfolios, Bausch + Lomb and Carl Zeiss Meditec hold strong positions, and specialists including NIDEK, HOYA, STAAR Surgical, Ziemer, Topcon, and Oertli compete across platforms and lenses.
  • Geographic reach: The leading participants operate global commercial and surgeon-education organizations, while high-volume regional manufacturers such as Aurolab serve large domestic and developing markets at low cost, and the tiered Asia-Pacific market supports both.
  • Product portfolio strength: Competitive advantage rests on offering an integrated portfolio spanning the phacoemulsification platform, femtosecond laser, premium intraocular lenses, and viscoelastics, since surgeons increasingly select an end-to-end refractive cataract solution rather than individual components.
  • Pipeline strength: Development is concentrated in next-generation phacoemulsification and integrated cataract-vitreoretinal platforms, femtosecond laser and robotic surgery, premium and full range of vision intraocular lenses, advanced materials, and AI-driven surgical planning.
  • Strategic partnerships: Collaboration spans surgeon education and training, integration of lenses with diagnostic biometry and surgical platforms, cataract-outreach alliances with nonprofit organizations, and partnerships that extend access in emerging markets.
  • M&A activity: Acquisition is a defining dynamic, exemplified by the Alcon acquisition of a robotic laser platform and the EssilorLuxottica acquisition of the Optegra ophthalmic clinic network, as the leaders build platform breadth and access.
  • Innovation focus: Innovation is shifting toward robotic and femtosecond laser-assisted surgery, premium and spectacle-independent intraocular lenses, AI-driven lens-power calculation and surgical guidance, and miniaturized and efficient surgical devices.
  • Regulatory standing: United States premarket approval and 510(k) clearance and European Union Medical Device Regulation certification are decisive competitive credentials, and the sequence of platform and premium-lens approvals has become a principal axis of competition among the leaders.

Cataract Surgery Devices Market Recent Developmental Activities

In April 2025, Alcon Inc. announced the launch of the UNITY Vitreoretinal Cataract System and the UNITY Cataract System, offering a versatile platform with both a combined console and a standalone cataract system, featuring first-to-market technologies including UNITY 4D Phaco, HYPERVIT 30K, and the UNITY Intelligent Fluidics system, designed to improve efficiency and surgical outcomes for cataract and vitreoretinal procedures. Strategic significance: the launch of a next-generation integrated platform by the market leader reinforced the strategic emphasis on combining advanced phaco technology with intelligent fluidics to deliver greater precision, stability, and efficiency with reduced energy use.

In March 2025, Alcon Inc. announced that Vivity, the widely implanted extended depth-of-focus intraocular lens, became available on its advanced Clareon lens material, with the Clareon Vivity having received CE Mark approval and beginning its commercial rollout across Europe in the second quarter of 2025. Strategic significance: migrating a leading extended depth-of-focus optic onto an advanced hydrophobic acrylic material combined premium optical performance with a material engineered to reduce posterior capsule opacification and glistenings, illustrating the dual axis of optical and material innovation in the premium lens segment.

Cataract Surgery Devices Market Segmentation

Cataract Surgery Devices Market Assessment by Product Type

  • Phacoemulsification Systems
  • Femtosecond Lasers
  • Intraocular Lenses
  • Viscosurgical Devices
  • Others

Cataract Surgery Devices Market Assessment by End-User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Cataract Surgery Devices Market Assessment by Geography

  • North America
  • United States Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Canada Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Mexico Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Europe
  • France Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Germany Cataract Surgery Devices Market Size in USD million (2023-2034)
  • United Kingdom Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Italy Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Spain Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Rest of Europe Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Asia-Pacific
  • China Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Japan Cataract Surgery Devices Market Size in USD million (2023-2034)
  • India Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Australia Cataract Surgery Devices Market Size in USD million (2023-2034)
  • South Korea Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Rest of the World
  • Middle East Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Africa Cataract Surgery Devices Market Size in USD million (2023-2034)
  • South America Cataract Surgery Devices Market Size in USD million (2023-2034)

Key Takeaways from the Cataract Surgery Devices Market Report Study

  • Market size analysis for the current cataract surgery devices market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global cataract surgery devices market.
  • Various opportunities available for competitors in the cataract surgery devices market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current cataract surgery devices market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for cataract surgery devices market growth in the future?

Target audience who can benefit from this Cataract Surgery Devices market report study

  • Herbal medicines product providers
  • Research organizations and consulting companies
  • Herbal medicines-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in cataract surgery devices
  • Various end-users who want to know more about the cataract surgery devices market and the latest technological developments in the cataract surgery devices market.

Frequently Asked Questions:

Q1. At what rate is the cataract surgery devices market expected to grow?

The global cataract surgery devices market is projected to grow at a compound annual growth rate of 5.07% during the forecast period from 2026 to 2034.

Q2. What is the current and projected size of the cataract surgery devices market?

The global cataract surgery devices market was valued at USD 9.15 billion in 2025 and is projected to reach USD 14.27 billion by 2034.

Q3. Which region dominates the cataract surgery devices market?

North America dominated the cataract surgery devices market with a 39% share in 2025, driven by the high prevalence of cataracts among an aging population, advanced healthcare infrastructure, strong adoption of femtosecond lasers and premium intraocular lenses, favorable reimbursement, and the presence of leading manufacturers, with the National Institutes of Health reporting that over 50% of those aged 80 and above have had cataracts or cataract surgery. Asia-Pacific is projected to record the fastest compound annual growth rate through 2034, driven by a large and aging population, significant unmet need, and expanding surgical capacity across China, India, and the wider region.

Table of Contents

1. Introduction

  • 1.1. Scope of the Report
  • 1.2. Market Segmentation
  • 1.3. Market Overview at a Glance

2. Executive Summary of Cataract Surgery Devices Market

  • 2.1. Key Highlights and Market Snapshot

3. Key Factors Impacting the Cataract Surgery Devices Market

  • 3.1. Market Drivers
    • 3.1.1. Growing Prevalence of Cataracts and Vision Impairment
    • 3.1.2. Increasing Prevalence of Lifestyle Disorders
    • 3.1.3. Rising Geriatric Population
    • 3.1.4. Technological Advancement in Devices and Procedures
  • 3.2. Market Restraints
    • 3.2.1. Risk of Complications Associated with Cataract Surgery
    • 3.2.2. Regulatory and Reimbursement Challenges
    • 3.2.3. High Cost and Pricing Pressure
  • 3.3. Market Opportunities
    • 3.3.1. Emergence of Robotic-Assisted Laser Surgeries
    • 3.3.2. Integration of AI and Digital Platforms

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1. The United States
  • 5.2. Europe
  • 5.3. Japan
  • 5.4. China

6. Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Cataract Surgery Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Phacoemulsification Systems
    • 7.1.2. Femtosecond Lasers
    • 7.1.3. Intraocular Lenses
    • 7.1.4. Viscosurgical Devices
    • 7.1.5. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Specialty Clinics
    • 7.2.3. Ambulatory Surgical Centers
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.1.2. Canada Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.1.3. Mexico Cataract Surgery Devices Market Size in USD million (2023-2034)
    • 7.3.2. Europe
      • 7.3.2.1. France Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.2.2. Germany Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.2.3. United Kingdom Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.2.4. Italy Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.2.5. Spain Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.2.6. Rest of Europe Cataract Surgery Devices Market Size in USD million (2023-2034)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.3.2. Japan Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.3.3. India Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.3.4. Australia Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.3.5. South Korea Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.3.6. Rest of Asia-Pacific Cataract Surgery Devices Market Size in USD million (2023-2034)
    • 7.3.4. Rest of the World
      • 7.3.4.1. Middle East Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.4.2. Africa Cataract Surgery Devices Market Size in USD million (2023-2034)
      • 7.3.4.3. South America Cataract Surgery Devices Market Size in USD million (2023-2034)

8. Cataract Surgery Devices Market Competitive Landscape

  • 8.1. Competitive Analysis
  • 8.2. Company Share Analysis (Premium Offering)

9. Cataract Surgery Devices Market Startup Funding and Investment Trends

10. Company and Product Profiles

  • 10.1. Alcon Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Company Snapshot
    • 10.1.3. Financial Overview
    • 10.1.4. Product Listing
    • 10.1.5. Strategic Initiatives / Entropy
  • 10.2. Johnson & Johnson Services, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Company Snapshot
    • 10.2.3. Financial Overview
    • 10.2.4. Product Listing
    • 10.2.5. Strategic Initiatives / Entropy
  • 10.3. Bausch Health Companies Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Company Snapshot
    • 10.3.3. Financial Overview
    • 10.3.4. Product Listing
    • 10.3.5. Strategic Initiatives / Entropy
  • 10.4. Carl Zeiss Meditec AG (ZEISS Group)
    • 10.4.1. Company Overview
    • 10.4.2. Company Snapshot
    • 10.4.3. Financial Overview
    • 10.4.4. Product Listing
    • 10.4.5. Strategic Initiatives / Entropy
  • 10.5. NIDEK CO., LTD.
    • 10.5.1. Company Overview
    • 10.5.2. Company Snapshot
    • 10.5.3. Financial Overview
    • 10.5.4. Product Listing
    • 10.5.5. Strategic Initiatives / Entropy
  • 10.6. HOYA Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Company Snapshot
    • 10.6.3. Financial Overview
    • 10.6.4. Product Listing
    • 10.6.5. Strategic Initiatives / Entropy
  • 10.7. STAAR Surgical Company
    • 10.7.1. Company Overview
    • 10.7.2. Company Snapshot
    • 10.7.3. Financial Overview
    • 10.7.4. Product Listing
    • 10.7.5. Strategic Initiatives / Entropy
  • 10.8. Ziemer Ophthalmic Systems AG
    • 10.8.1. Company Overview
    • 10.8.2. Company Snapshot
    • 10.8.3. Financial Overview
    • 10.8.4. Product Listing
    • 10.8.5. Strategic Initiatives / Entropy
  • 10.9. Topcon Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Company Snapshot
    • 10.9.3. Financial Overview
    • 10.9.4. Product Listing
    • 10.9.5. Strategic Initiatives / Entropy
  • 10.10. Oertli Instrumente AG
    • 10.10.1. Company Overview
    • 10.10.2. Company Snapshot
    • 10.10.3. Financial Overview
    • 10.10.4. Product Listing
    • 10.10.5. Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Global Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Table 2: Global Cataract Surgery Devices Market Size by Product Type in USD million (2023-2034)
  • Table 3: Global Cataract Surgery Devices Market Size by End-User in USD million (2023-2034)
  • Table 4: Cataract Surgery Devices Market Size in North America in USD million (2023-2034)
  • Table 5: Cataract Surgery Devices Market Size in the United States in USD million (2023-2034)
  • Table 6: Cataract Surgery Devices Market Size in Canada in USD million (2023-2034)
  • Table 7: Cataract Surgery Devices Market Size in Mexico in USD million (2023-2034)
  • Table 8: Cataract Surgery Devices Market Size in Europe in USD million (2023-2034)
  • Table 9: Cataract Surgery Devices Market Size in France in USD million (2023-2034)
  • Table 10: Cataract Surgery Devices Market Size in Germany in USD million (2023-2034)
  • Table 11: Cataract Surgery Devices Market Size in the United Kingdom in USD million (2023-2034)
  • Table 12: Cataract Surgery Devices Market Size in Italy in USD million (2023-2034)
  • Table 13: Cataract Surgery Devices Market Size in Spain in USD million (2023-2034)
  • Table 14: Cataract Surgery Devices Market Size in the Rest of Europe in USD million (2023-2034)
  • Table 15: Cataract Surgery Devices Market Size in Asia-Pacific in USD million (2023-2034)
  • Table 16: Cataract Surgery Devices Market Size in China in USD million (2023-2034)
  • Table 17: Cataract Surgery Devices Market Size in Japan in USD million (2023-2034)
  • Table 18: Cataract Surgery Devices Market Size in India in USD million (2023-2034)
  • Table 19: Cataract Surgery Devices Market Size in Australia in USD million (2023-2034)
  • Table 20: Cataract Surgery Devices Market Size in South Korea in USD million (2023-2034)
  • Table 21: Cataract Surgery Devices Market Size in the Rest of Asia-Pacific in USD million (2023-2034)
  • Table 22: Cataract Surgery Devices Market Size in the Rest of the World in USD million (2023-2034)
  • Table 23: Cataract Surgery Devices Market Size in the Middle East in USD million (2023-2034)
  • Table 24: Cataract Surgery Devices Market Size in Africa in USD million (2023-2034)
  • Table 25: Cataract Surgery Devices Market Size in South America in USD million (2023-2034)
  • Table 26: Cataract Surgery Devices Market Competitive Landscape
  • Table 27: Cataract Surgery Devices Market Startup Funding and Investment Trends

List of Figures

  • Figure 1: Cataract Surgery Devices Market Drivers
  • Figure 2: Cataract Surgery Devices Market Restraints
  • Figure 3: Cataract Surgery Devices Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis of the Cataract Surgery Devices Market (the United States)
  • Figure 6: Regulatory Analysis of the Cataract Surgery Devices Market (Europe)
  • Figure 7: Regulatory Analysis of the Cataract Surgery Devices Market (Japan)
  • Figure 8: Regulatory Analysis of the Cataract Surgery Devices Market (China)
  • Figure 9: Porter's Five Forces Analysis of the Cataract Surgery Devices Market
  • Figure 10: Competitive Analysis of the Cataract Surgery Devices Market
  • Figure 11: Global Cataract Surgery Devices Market Size in USD million (2023-2034)
  • Figure 12: Global Cataract Surgery Devices Market Size by Product Type in USD million (2023-2034)
  • Figure 13: Global Cataract Surgery Devices Market Size by End-User in USD million (2023-2034)
  • Figure 14: Cataract Surgery Devices Market Size in North America in USD million (2023-2034)
  • Figure 15: Cataract Surgery Devices Market Size in the United States in USD million (2023-2034)
  • Figure 16: Cataract Surgery Devices Market Size in Canada in USD million (2023-2034)
  • Figure 17: Cataract Surgery Devices Market Size in Mexico in USD million (2023-2034)
  • Figure 18: Cataract Surgery Devices Market Size in Europe in USD million (2023-2034)
  • Figure 19: Cataract Surgery Devices Market Size in France in USD million (2023-2034)
  • Figure 20: Cataract Surgery Devices Market Size in Germany in USD million (2023-2034)
  • Figure 21: Cataract Surgery Devices Market Size in the United Kingdom in USD million (2023-2034)
  • Figure 22: Cataract Surgery Devices Market Size in Italy in USD million (2023-2034)
  • Figure 23: Cataract Surgery Devices Market Size in Spain in USD million (2023-2034)
  • Figure 24: Cataract Surgery Devices Market Size in the Rest of Europe in USD million (2023-2034)
  • Figure 25: Cataract Surgery Devices Market Size in Asia-Pacific in USD million (2023-2034)
  • Figure 26: Cataract Surgery Devices Market Size in China in USD million (2023-2034)
  • Figure 27: Cataract Surgery Devices Market Size in Japan in USD million (2023-2034)
  • Figure 28: Cataract Surgery Devices Market Size in India in USD million (2023-2034)
  • Figure 29: Cataract Surgery Devices Market Size in Australia in USD million (2023-2034)
  • Figure 30: Cataract Surgery Devices Market Size in South Korea in USD million (2023-2034)
  • Figure 31: Cataract Surgery Devices Market Size in the Rest of Asia-Pacific in USD million (2023-2034)
  • Figure 32: Cataract Surgery Devices Market Size in the Rest of the World in USD million (2023-2034)
  • Figure 33: Cataract Surgery Devices Market Size in the Middle East in USD million (2023-2034)
  • Figure 34: Cataract Surgery Devices Market Size in Africa in USD million (2023-2034)
  • Figure 35: Cataract Surgery Devices Market Size in South America in USD million (2023-2034)
  • Figure 36: Cataract Surgery Devices Market Competitive Landscape
  • Figure 37: Cataract Surgery Devices Market Startup Funding and Investment Trends